NPI registry status
Active
2026 NPPES data Specialist NPI 1285692053 MD
Verify on CMS → Rocco Dipaola, MD
Specialist in Toms River, New Jersey.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 69,567 in Specialist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
4K
Medicare Part D claims · 835 beneficiaries · Specialist avg: 2K
Generic prescribing
84%
generic claims · 16% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75.8/100
▼ 8 pts below national avg 83.5 · Above neutral
Industry payments
$1.6K
102 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Rocco Dipaola, MD reported a CMS MIPS final score of 75.8/100 - below the 83.5 national average - and filed 4,274 Medicare Part D claims in 2024.
- 75.8/100
- MIPS score · -8 vs avg
- 4K
- Part D claims, 2024
- 84%
- generic prescribing
- $1.6K
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Rocco Dipaola, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1285692053), first enumerated 05/02/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 4,274 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 75.8/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$1.6K in reported industry payments (102 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1285692053 · Specialist
NPI-10 · ENUM-LEGACY · TAX-MEGA · MIPS-BELOW · RX-MID · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1285692053
- ENUM-LEGACY 2006
- TAX-MEGA 70K Specialist
- MIPS-BELOW 75.8/100
- RX-MID 4,274
- BOOK-LIGHT 1,979 in New Jersey
- PHOTO-FINISH David Kramer, M.D. · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Dario Beltran, M…
Dario Beltran, MD
75.7 MIPS pts
- Dipaola · this p…
Dipaola · this provider
75.8 MIPS pts
- Ahmet Aksu, M.D.…
Ahmet Aksu, M.D.
75.8 MIPS pts
- David Kramer, M.…
David Kramer, M.D.
75.8 MIPS pts
- Murray Solomon, …
Murray Solomon, M.D.
75.8 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Rocco Dipaola, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
76 ≥ 15th percentile 15% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Rocco Dipaola, MD sits
This provider among specialist peers
Across the 4,261 specialist providers who report both Medicare Part D prescribing and a MIPS quality score, Rocco Dipaola, MD writes more Part D claims than 88% of them and scores higher on MIPS quality than 27% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one specialist peer from a representative sample of 60; the gold marker is Rocco Dipaola, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Rocco Dipaola, MD?
Below national averagePrimary specialty
Specialist
Medicare Part D claims
4,274 180% vs specialty avg
MIPS final score
75.8/100 7.7 pts vs avg
Specialty distribution in New Jersey
How Specialist compares to other specialties among New Jersey providers
Medicare quality performance, MIPS
Rocco Dipaola, MD's 2023 MIPS final score plotted against the Specialist national average
- MIPS Final Score
- 75.8/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1285692053 |
|---|---|
| Specialty | Specialist |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 05/02/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75.8046
Final Score
Measured-score avg: 83.5
68.6551
Quality
50.6935
Cost
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Rocco Dipaola, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Hackensack Meridian Health Medical Group - Specialty Care PC
Neptune, NJ
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Rocco Dipaola, MD. Source: openpaymentsdata.cms.gov.
Total received
$1.6K
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
Rocco Dipaola, MD - brand share 16.0%
Specialist average
16% brand-name claims vs 84% generic, on 4,274 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
4,274
Total Claims
$2.4M
Total Drug Cost
835
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 9,081.067
- Total Day Supply
- 268,416
- Brand vs Generic
- 16% brand / 84% generic
- Brand Drug Cost
- $2.2M
- Generic Drug Cost
- $167K
- Opioid Claims
- 43 (1.0% rate)
Patient Demographics
- Average Patient Age
- 75.2 years
- Avg HCC Risk Score
- 1.81
- Gender Split
- 47% female / 53% male
- Age Distribution
- <65: 62, 65-74: 287, 75-84: 397, 85+: 89
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Rocco Dipaola, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Carbidopa-Levodopa
Carbidopa-Levodopa
1,186 claims
- Rytary 185
Rytary
185 claims
- Donepezil Hcl 174
Donepezil Hcl
174 claims
- Amantadine 158
Amantadine
158 claims
- Primidone 155
Primidone
155 claims
- Gabapentin 150
Gabapentin
150 claims
- Botox 142
Botox
142 claims
- Carbidopa-Levodopa… 130
Carbidopa-Levodopa Er
130 claims
| Drug | Claims |
|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 1,186 |
| Rytary Carbidopa/Levodopa | 185 |
| Donepezil Hcl | 174 |
| Amantadine Amantadine Hcl | 158 |
| Primidone | 155 |
| Gabapentin | 150 |
| Botox Onabotulinumtoxina | 142 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 130 |
| Escitalopram Oxalate | 115 |
| Propranolol Hcl | 109 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Specialist Overview
How Rocco Dipaola, MD fits within the Specialist landscape nationally.
69,567
Specialist Providers in US
55
States with Specialist
1,524
Avg Claims per Provider
Rocco Dipaola, MD's 4,274 claims are above the specialty average of 1,524.
Nationwide Specialist peers with similar MIPS or enrollment year
Two federal-record peer sets for Dipaola, both outside New Jersey so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (75.8 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Specialist Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Dipaola.
One of 1,979 Specialist providers enrolled in New Jersey, 5 are shown here.
Lisa Abate
Hainesport, NJ
Dr. Ziad Abbud
MD
Neptune, NJ
Dr. Yaakov Abdelhak
M.D.
Hackensack, NJ
Aliyah Abdullah-Griffin
Carteret, NJ
Vanjelo Abellar
RPT
Carteret, NJ
Compare Specialist nationally: see state-by-state distribution →
Frequently Asked Questions
What is Rocco Dipaola, MD's specialty? ▼
Rocco Dipaola, MD specializes in Specialist and practices in Toms River, New Jersey. Credentials: MD.
How much does Rocco Dipaola, MD prescribe under Medicare Part D? ▼
In 2024, Rocco Dipaola, MD wrote 4,274 Medicare Part D claims totaling $2.4M in drug costs for 835 beneficiaries.
What is Rocco Dipaola, MD's Medicare quality score? ▼
Rocco Dipaola, MD has a CMS MIPS Final Score of 75.8/100 (Quality: 68.7, Cost: 50.7). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Rocco Dipaola, MD located? ▼
Rocco Dipaola, MD is located at 633 RTE 37 W, Toms River, NJ, 08755. Phone: (732) 240-4787.
What is Rocco Dipaola, MD's NPI number? ▼
Rocco Dipaola, MD's National Provider Identifier (NPI) is 1285692053, issued on 05/02/2006.
Does Rocco Dipaola, MD prescribe more brand-name or generic drugs? ▼
Rocco Dipaola, MD's prescribing is 16% brand-name and 84% generic drugs by claim count, with $2.2M in brand drug costs.
Does Rocco Dipaola, MD prescribe opioids? ▼
Yes, Rocco Dipaola, MD had 43 opioid claims in 2024 with an opioid prescribing rate of 1.0%.
How many Specialist providers are there in the US? ▼
There are 69,567 Specialist providers across 55 states in the US. The average Specialist provider writes 1,524 Medicare Part D claims per year.
What drugs does Rocco Dipaola, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Rocco Dipaola, MD's most frequently prescribed drugs include Carbidopa-Levodopa, Rytary, Donepezil Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Rocco Dipaola, MD accept Medicare? ▼
Rocco Dipaola, MD appears in CMS Medicare data with 4,274 Part D claims and 835 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Rocco Dipaola, MD's credentials? ▼
Rocco Dipaola, MD's NPI is 1285692053 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.